2 years ago

Acurable's Wireless Sleep Apnea Diagnostic Device Gains FDA Clearance

  • Acurable, a U.K

  • medtech startup, has gained FDA clearance for a novel wireless diagnostic device for remote detection of obstructive sleep apnea (OSA)

  • The startup, founded in 2016, is the brainchild of Imperial College professor Esther Rodriguez-Villegas, who spent 1.5 decades researching acoustic sensing for respiratory biomarkers

  • Acurable's wearable is already being used in the U.K

  • and EU

  • The startup raised an €11 million Series A round in October 2022, with investors including Alma Mundi Ventures, Kindred Capital, and KHP Ventures

  • Acurable's device offers a patient-friendly and cost-effective way to diagnose sleep apnea, allowing for remote testing and self-administration.

      • ProblemHealthcare

      "Diagnosing sleep apnea is often costly and inconvenient, relying on uncomfortable overnight tests in specialized centers or complex at-home setups that are prone to errors."

      Solution

      "Acurable offers a discreet, wireless, single-use wearable device, the AcuPebble, that patients can easily apply at home. It tracks breathing patterns overnight and provides clinicians with data to diagnose sleep apnea efficiently and comfortably."

      Covered on